Patents

2-Phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands. Coppo, Frank Teen; Maskell, Emma S. L.; Redshaw, Sally; Skidmore, John; Ward, Robert William; Wilson, David Matthew. WO 2007138033

Novel hydroxyethylamine and ketone compounds having Asp2 inhibitory activity. Demont, Emmanuel, Hubert; Redshaw, Sally; Walter, Daryl, Simon. WO 2006103088

Tricyclic indole derivatives for use in the treatment of Alzheimer’s disease. Demont, Emmanuel Hubert; Redshaw, Sally; Walter, Daryl Simon. WO 2006040148

Preparation of substituted hydroxyethylamine compounds for treating Alzheimer’s disease. Demont, Emmanuel Hubert; Redshaw, Sally; Walter, Daryl Simon. WO 2006040151

Heterocyclic ketone compounds for treating Alzheimer’s disease. Demont, Emmanuel Hubert; Redshaw, Sally; Walter, Daryl Simon. WO 2006040149

Substituted hydroxyethylamine compounds for treating Alzheimer’s disease. Demont, Emmanuel Hubert; Redshaw, Sally; Walter, Daryl Simon. WO 2006040151

Preparation of N,N’-substituted-1,3-diamino-2-oxopropane derivatives as Asp2 inhibitors for use against diseases characterized by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer’s disease. Demont, Emmanuel Hubert; Redshaw, Sally; Walter, Daryl Simon. WO 2005113525

Preparation of tricyclic indole hydroxyethylamine derivatives and their use in the treatment of Alzheimer’s disease. Redshaw, Sally; Demont, Emmanuel Hubert; Walter, Daryl Simon. WO 2005058915

1,2,4-Triazin-3-yl-Hydrazine Or 5H-1,2,4-Triazino[5,6-b]indol-3-yl-Hydrazine Compounds As Inhibitors Of BACE Useful In The Treatment Of Alzheimer’s Disease. John, Derek Edward; Willems, Henriette; Harris, William. WO 2004063196

Sulphonylamino Derivatives For The Treatment Of Alzheimer’s Disease. Willems, Henriette; Harris, William. WO 2004020402

Pyrimido Compounds Having Antiproliferative Activity. Chen, Yi; Liu, Jin-Jun; Harris, William; Liu, Emily; Daniewski, Andrzej Robert; Kabat, Marek Michal; Michoud, Christophe. WO 2004018472

Preparation of hydroxydiaminopropyl tricyclic indolecarboxamides for treatment of β-amyloid related disease. Demont, Emmanuel Hubert; Redshaw, Sally; Walter, Daryl Simon. WO 2004094430

Preparation of hydroxyethylamine derivatives for the treatment of Alzheimer’s disease. Demont, Emmanuel Hubert; Redshaw, Sally; Walter, Daryl Simon. WO 2004080376

Preparation of hydroxyethylamine derivatives for the treatment of Alzheimer’s disease. Demont, Emmanuel H.; Faller, Andrew; MacPherson, David Timothy; Milner, Peter Henry; Naylor, Alan; Redshaw, Sally; Stanway, Steven James; Vesey, David R.; Walter, Daryl S. WO 2004050619

Preparation of 3-(1,1-dioxotetrahydro-1,2-thiazin-2-yl) or 3-(1,1-dioxo-isothiazolidin-2-yl) substituted benzamide compounds for treatment of Alzheimer’s disease. Demont, Emmanuel Hubert; Redshaw, Sally; Walter, Daryl Simon. WO 2004111022

Preparation of peptide mimetics as HIV protease inhibitors. Demont, Emmanuel; Martin, Joseph Armstrong; Redshaw, Sally; Swallow, Steven. WO 2003029206

Thienopyrrolidinones. Gill, Adrian Liam; Harris, William. WO 200202567

Preparation of imidazolylalkyl-aminopiperidines as HIV inhibitors. Edlin, Christopher David; Redshaw, Sally; Smith, Ian Edward David; Walter, Daryl Simon. WO 200279186

Preparation of decahydroisoquinoline-3-carboxamide amino acid derivatives as HIV protease inhibitors. Martin, Joseph Armstrong; Redshaw, Sally; Swallow, Steven; Thomas, Gareth John. WO 200242277

Preparation of alkylamino substituted bicyclic nitrogen heterocycles for pharmaceutical use as inhibitors of p38 protein kinase. Dunn, James Patrick; Fisher, Lawrence Emerson; Goldstein, David Michael; Harris, William; Hill, Christopher Huw; Smith, Ian Edward David; Welch, Teresa Rosanne. WO 200129042

Preparation of alkylamino substituted bicyclic nitrogen heterocycles for pharmaceutical use as inhibitors of p38 protein kinase. Dunn, James Patrick; Goldstein, David Michael; Harris, William; Smith, Ian Edward David; Welch, Teresa Rosanne. WO 200129041

Preparation of pyrimidopyrimidinones as T-cell tyrosine kinase inhibitors. Harris, William; Hill, Christopher Huw; Smith, Ian Edward David. WO 200024744

Preparation of substituted (pyrido[1,2-a]indolyl)pyrrole as drugs. Harris, William; Hill, Christopher Huw; Lawton, Geoffrey. EP 624586

Preparation of N-(asparaginylaminohydroxyphenylbutyl)-decahydroisoquindine-3-carboxamides as HIV protease inhibitors. Martin JA, Redshaw S. EP 432695

Amino alcohols. Parkes KEB, Redshaw S, Thomas GJ. EP 432694

Preparation of peptide amides as human immunodeficiency virus inhibitors. Handa BK, Machin PJ, Martin JA, Redshaw S, Thomas GJ. EP 346847

Preparation of 4-aryl- and 4-(N-heteroaryl)-2H-1-benzopyrans as potassium channel activators. Attwood MR, Jones PS, Redshaw S. EP 298452

Octahydro-10-oxo-6H-pyridazo[1,2-a][1,2]diazepine derivatives, intermediates and process for their preparation, and medicaments containing them. Lawton G, Redshaw S. EP 271795

Pyridazinodiazepinecarboxylates and analogs as antihypertensives. Hassall CH, Lawton G, Redshaw S. EP 172552

Bicyclic carboxylic acids and their alkyl and aralkyl esters. Attwood MR, Hassall CH, Lambert RW, Lawton G, Redshaw S. DE 3317290


Top